UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 10
October-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2510198


Registration ID:
570290

Page Number

b802-b814

Share This Article


Jetir RMS

Title

Liquid Biopsy Innovations for Early Cancer Detection

Abstract

The future of oncology diagnostics lies in detecting cancer before it reveals itself clinically, and liquid biopsy is emerging as the key to that future. Conventional diagnostic approaches, including imaging and tissue biopsy, often fall short in sensitivity, invasiveness, and real-time monitoring capacity. Liquid biopsy transforms this landscape by enabling the detection of tumor-derived materials such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and microRNAs in easily accessible body fluids. This innovation offers a minimally invasive, repeatable, and dynamic window into tumor evolution. Breakthroughs in next-generation sequencing (NGS), digital PCR, nanotechnology-driven biosensors, and artificial intelligence have greatly enhanced the precision, scalability, and predictive value of liquid biopsy assays. Beyond early diagnosis, these tools now underpin multi-cancer early detection (MCED) platforms and personalized treatment monitoring. However, challenges, such as low analyte concentrations, standardization gaps, and cost barriers, still limit widespread clinical integration. This paper reviews the latest technological, methodological, and translational innovations shaping the liquid biopsy frontier, emphasizing its transformative potential for early detection and precision oncology. As science progresses toward universal, non-invasive screening, liquid biopsy is poised to shift cancer diagnostics from reactive treatment to proactive prevention.

Key Words

Liquid Biopsy, Exosomes, Precision, NGS, Low Analyte, Invasive

Cite This Article

"Liquid Biopsy Innovations for Early Cancer Detection", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 10, page no.b802-b814, October-2025, Available :http://www.jetir.org/papers/JETIR2510198.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Liquid Biopsy Innovations for Early Cancer Detection", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 10, page no. ppb802-b814, October-2025, Available at : http://www.jetir.org/papers/JETIR2510198.pdf

Publication Details

Published Paper ID: JETIR2510198
Registration ID: 570290
Published In: Volume 12 | Issue 10 | Year October-2025
DOI (Digital Object Identifier):
Page No: b802-b814
Country: Chandigarh, Chandigarh, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00012

Print This Page

Current Call For Paper

Jetir RMS